Theo-24 Capsule, Extended Release
Pricing Report NDC 52244-400-10
View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Current Package Pricing Information
The latest wholesale acquisition cost for Theo-24 (NDC 52244-400-10) is $9.79324 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 01, 2026.
As a a human prescription drug provided by Endo Usa, Inc., this medication is distributed in a 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $9.79324 Per EA
Pricing Unit
Effective Date
Jan 01, 2026
Billable Units
100 EA
Estimated Package Price
$979.32
Data Status
As of Jul 08, 2026
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Historical Pricing Trends & Acquisition Cost Benchmarks
Since Jan 2015, the NADAC wholesale price for (NDC ) has moved within a range of $3.41892 to $9.79324 per EA. Over this 10 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.
Price Range
$3.4189 - $9.7932
$3.4189 - $9.7932
Market Volatility
186.44% Variance
186.44% Variance
Latest Trend
3.00%
3.00%
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Jan 01, 2026 | $9.79324 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2026 | $9.79324 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2026 | $9.79324 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 17, 2025 | $9.50800 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 19, 2025 | $9.49358 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 22, 2025 | $9.49358 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 17, 2025 | $9.49358 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2025 | $9.51382 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2025 | $9.51382 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2025 | $9.51382 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 18, 2024 | $8.65680 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 20, 2024 | $8.46262 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 23, 2024 | $8.46262 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 18, 2024 | $8.46262 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 21, 2024 | $8.46262 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 17, 2024 | $8.46262 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2024 | $8.69028 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2024 | $8.69028 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2023 | $7.90744 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2023 | $7.90744 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2022 | $7.19519 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2022 | $7.19519 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2021 | $6.54703 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 01, 2021 | $6.54703 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 06, 2020 | $5.95726 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 06, 2020 | $5.95726 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 23, 2019 | $5.42062 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 23, 2019 | $5.42062 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 04, 2019 | $5.43693 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 04, 2019 | $5.43693 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 04, 2019 | $5.43693 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 05, 2018 | $4.94711 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 05, 2018 | $4.94711 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 01, 2017 | $4.50143 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 01, 2017 | $4.50143 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 01, 2016 | $4.09589 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 01, 2016 | $4.09589 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 01, 2016 | $4.09589 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 18, 2015 | $3.72350 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 18, 2015 | $3.72350 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 18, 2015 | $3.72350 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 14, 2015 | $3.41892 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 14, 2015 | $3.41892 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
Pricing Methodology Legend
- Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
- Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
- Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
- Code 4: The NADAC was carried forward from the previous file.
- Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: July 08, 2026
